2. View Report Details
Executive Summary
Clinical laboratory testing market is one of the prime segments of healthcare industry. The market for clinical
laboratory testing has seen significant growth in the recent years and it is expected that the market will
continue to grow even further in near future. The growth of the market is mainly driven by global aging
demographics and healthcare reforms.
The US was the largest market for clinical laboratory testing. In 2010, the clinical laboratory testing market
has registered significant growth compared to the previous year. In the US, Clinical pathology segment
recorded higher sales by value compared to other segments such as Anatomical pathology, Molecular
pathology, and Cytology. In 2010, the hospital based labs in the US have recorded higher sales compared to
independent labs and physician office labs.
Other key markets for clinical laboratory testing include Europe and Australia. Within Europe, France and
Germany are the key market for clinical laboratory testing. The clinical laboratory testing market in Australia
has significant growth opportunity in near future as the GDP and aging population of the country is growing
rapidly. During 2010-2011, the number of pathology collection centers in Australia has grown significantly to
meet the growing demand in the country.
In 2010, Roche was the market leader of global in-vitro diagnostics market followed by Siemens and Beckman
Coulter, whereas, the US clinical laboratory market was led by Quest Diagnostics followed by LabCorp. In
Australian laboratory testing market, Sonic Healthcare was the market leader followed by primary healthcare
and Healthscope.
The report analyzes the clinical laboratory testing market, with focus on the US, Europe and Australia. The
growth drivers, trends and challenges are also discussed. The major regional players have been profiled,
highlighting their strategies for this growing market.
3. Global clinical laboratory market has grown significantly over the last five years
mainly on the back of strong growth in the US, Australia, and European markets…
Clinical Laboratory Market in the US (US$ Billion)
The US clinical laboratory testing market has
generated revenues of …………………… US$...... billion
in ………………….., registering an increase of about
….%, ………………………………………………………………………
US$ Billion
……………………………………………………………..growth in
the number of ……………………….in the US. The Centers
for …………………………………………………………………………….
……………………………………………………………………………
The clinical pathology segment was …………………….
…………………………………………………………………..…,Clinical
pathology market segment within tests have
accounted for about ……………..% of the US clinical lab
market by revenue, followed by ………………….. tests,
2004 2005 2006 2007 2008 2009 2010
…………………………………………………………………pathology
Clinical Lab Market in the US by Type of Tests tests have accounted for about ……..% of the US
clinical lab market followed by …………… tests with
………………………………………………………..%. It is expected
that…………….……………………………………………………………
………………………..
Molecular Pathology Cytology
Clinical Pathology Anatomical Pathology
Abuse of Drugs
4. The US clinical lab market was led by hospital based labs...combined with strong
growth in Esoteric test and Molecular diagnostics test market…
The US Clinical Lab Market by Types of Labs Hospital based labs have accounted for about ….% of
the US clinical labs market by test volume in 2010
followed by …………………………………………………………….
In the US, molecular diagnostics market accounted
for about ….% of the …………………. testing market in
2010, followed by blood screening (….%), genetic
testing (….%), cancer tests (…..%), and others (….%).
……………………………………………………………………………….
In 2010, the esoteric testing market generated total
revenue of approximately US$.................. billion.
…………………………………….
Physician Office Labs Independent Labs
Hospital Based Labs
Esoteric Test Market in the US
Infectious Disease Testing Market in the US
Others Molecular Dignostics Vitamin D Others
Genetic Testing Cancer HIV Chlamydia/GC DNA Probe
Antinuc lear Antibody (ANA) AFP/Quad
Blood Screening
5. Clinical Laboratory Market in Australia declined in recent years….however, the
market is expected to grow due to growing GDP and aging population…
Pathology Services Provided in Australia Pathology Benefits Paid in Australia
US$ Million
Millions
Nov-03Nov-04Nov-05Nov-06Nov-07Nov-08Nov-09Nov-10 2003 2004 2005 2006 2007 2008 2009 2010
• In the Australian Healthcare industry, pathology services provided ………………….by approximately ….% to … million in
……………………………… compared to …………million in ………………………. However the same increased by about
……………..…% compared to……………………………………………………………………………………………..
• The pathology benefits paid decreased from US$............. million (AUD…. million) in November 2009 to
US$...........million (AUD…. million) in November 2010, but the same increased by approximately ………….% compared
………………………………………………………………………………………………………………..…………………., ………..and ………………. had to
increase …………… to maintain pathology revenue growth rates…………………………………………………………………..
6. View Report Details
Table of Contents Tables and Charts
1. Overview Type of Clinical Laboratory Tests
1.1 Overview of Laboratory Testing
1.2 Types of Clinical Laboratory Tests Worldwide POCT Market Revenues, 2009-2010
1.3 Providers of Clinical Laboratory Tests Global Point of Care Diagnostics Market, 2010
2. Clinical Laboratory Testing - Market Overview Healthcare Expenditure in the US, 2010
2.1 Global Point-of-Care Testing The US Clinical Laboratory Testing Market, 2004-2010
Overview
Market Value The US Clinical Lab Market by Types of Tests, 2010
The US Clinical Lab Market by Types of Labs, 2010
2.2 Clinical Laboratory Testing Market in the US
Market Value Infectious Disease Testing Market in the US, 2010
Type of Tests Esoteric Test Market in the US, 2010
Type of Labs
Market Segments Value of Laboratory Mergers & Acquisitions in the US, 2005-
2010
2.3 Clinical Laboratory Testing Market in Europe CLIA Accredited Laboratories in the US, 2004-2014F
Overview
Market Value Coverage of Insurance in the US Adult Population, 2008-2010
Europe’s Clinical Diagnostics Market, 2010
2.4 Clinical Laboratory Market in Australia
Overview Market Value of Top 10 Pathological Tests in Australia, 2010
Top Providers Number of Pathology Collection Centers in Australia, 2010-
Growth of Collection Centers
Pathology Services Provided in Australia, Nov 03-Nov 10
3. Key Trends Pathology Benefits Paid in Australia, Nov 03-Nov 10
3.1 Science and Technology Advances
3.2 Consolidation among Major Players Growth in the US Aging Population, 2004-2014F
3.3 Growing Market for Point of Care Diagnostics
3.4 Huge Growth Opportunity in the Emerging Market
7. View Report Details
4. Growth Drivers Growth in the US Personal Healthcare Spending, 2004-2014F
4.1 Growing Aging Population Market Share of Major Players in the Global Diagnostics Products
4.2 Increased Health Care Spending on Clinical Services Market, 2010
4.3 Positive Impact of the US Healthcare Reform
The Clinical Lab Market Breakdown by Test Volume in the US, 2010
5. Significant Developments The US Lab Industry Market Share by Revenue, 2010
5.1 LabCorp Offered New FDA Approved Test for Ovarian
Malignancy Market Share of Major Players in the Reference Lab market by
5.2 Quest Diagnostics Developed CAH Tests Revenue in the US, 2010
5.3 LabCorp Offered a New Companion Diagnostic Revenue of Major Players in the US Anatomic Pathology Market by
Revenue, 2010
6. Competitive Landscape
6.1 Competitive Scenario in the US Market Share by Revenue of Major Players in Australian Pathology
6.2 Competitive Scenario in Australia Market, 2011
6.3 Competitive Scenario in Germany Market Share of Major Players in the Pathology Collection Centers
in Australia, 2011
7. Company Profiles
7.1 Quest Diagnostics Market Share of Major Players in German Pathology Market, 2010
Business Description Quest Diagnostic’s Revenues by Business Segments, 2011
Key Financials
Business Strategies Quest Diagnostic’s Revenues and Net Income, 2006-2010
Continuously Drive Six Sigma Quality LabCorp’s Net Sales by Business Segments, 2011
Leveraging Assets and Capabilities
LabCorp’s Revenues and Net Income, 2007-2011
7.2 Laboratory Corporation of America Holdings Sonic Healthcare’s Revenues by Business Segments, 2011
Business Description
Key Financials Sonic Healthcare’s Revenues and Net Income, 2007-2011
Business Strategies Healthscope’s Revenues by Business Segments, 2010
Growth through Acquisition Strategy
Continuing Scientific Innovation Healthscope’s Revenues and Net Income, 2009-2010
The US Clinical Laboratory Market Forecast, 2011E-2016F
8. View Report Details
7.3 Sonic Healthcare Limited
Tables
Business Description
Table 2.1: Sites of POC Testing
Key Financials
Business Strategies Table 2.2: CLIA Laboratories by Type of Facilities in the US, Dec
Ethical Corporate Governance 2010
Achieving Medical Leadership
Table 2.3: European Diagnostic Testing Scenario
7.4 Healthscope Ltd. Table 6.1: Change in Pathology Collection Centers in Australia, Jun
Business Description 10-Dec10
Key Financials
Table 8.1 Dependent & Independent Variables, 2004– 2011
Business Strategies
Efficient Credit Risk Management Table 8.2 Correlation Matrix
Ethical Trading of Securities
Table 8.3 Model Summary – Coefficient of Determination
8. Market Outlook Table 8.4 Regression Coefficients Output
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis
9. Contact Us:
View Report Details
These are abridged and sanitized sample pages from the comprehensive report on the “Global Clinical Laboratory Testing
Market”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
Vikas Gupta T. +91-120-4130959
BD Manager C: +91-9811715635
vikas@konceptanalytics.com
www.konceptanalytics.com
